CMX157

DRUG3 trials

Sponsors

Jazz Pharmaceuticals, ContraVir Pharmaceuticals, Inc.

Conditions

HealthyInfectious Disease

Phase 1

A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers

CompletedNCT01080820

Jazz PharmaceuticalsHealthy

Start: 2010-06-30End: 2010-12-31Target: 36Updated: 2011-07-04

A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects

CompletedNCT02585440

ContraVir Pharmaceuticals, Inc.Infectious Disease

Start: 2016-04-30End: 2016-09-30Updated: 2017-02-02

Phase 2

Phase 2, Multiple Ascending Dose Proof of Concept Study

CompletedNCT02710604

ContraVir Pharmaceuticals, Inc.Infectious Disease

Start: 2016-05-31End: 2017-07-18Updated: 2017-09-13